Where China + US BioPharma Clinical Development Leaders Meet
November 9-11, 2022 - Shanghai, China
Now in its 14th year, the annual CHINATRIALS Summit is the established must-attend industry-focused event for global clinical development executives interested in China development.
CHINATRIALS brings together 450+ senior clinical development executives from multinational biopharmaceutical companies, domestic pharmaceutical and new start-up biotechs.
The Summit covers a wide range of important topics for the Chinese market including regulatory policy, clinical strategy development, clinical trial design, registering imported drugs, and more. It is the only event you need to attend this year to stay updated on the scientific AND business sides of China's fast-moving clinical development industry.
TBA - Cambridge, MA, USA
2019's inaugural CHINATRIALS+US Summit brought together US and Chinese innovative biotechs amidst the backdrop of China's recent major regulatory reforms. For Chinese biotechs, these changes ushered in a boom of new domestic innovative biotechs looking to conduct clinical trials in the US and for US biotechs, streamlined regulations that makes it easier to export their innovative treatments to China.
The Summit will bring together 100+ clinical development leaders from US biotechs interested in entering the China market and Chinese innovative biotechs interested in launching clinical trials in the US.
While the inaugural event highlighted greatly the "what" and "why" of these new cross-border development opportunities, this year's discussion topics will focus much more on the "how." We look forward to seeing you this July in Cambridge to continue discussion on how to best implement exciting global development strategy!